Skip to content
ApprovedFDA approvedStrong evidence

Lemborexant

Prescription insomnia medicine (Dayvigo) that blocks orexin, which keeps the brain awake; approved in the US.

Sleep SupportOrexin AntagonistSleep SupportOrexin Antagonistnoo.affects.orexinnoo.affects.sleepAnti-fatigue
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassSleep Support · Orexin Antagonist
Primary targetDual orexin (OX1/OX2) receptor antagonism
Targets3 receptor targets
Half-life~17-19 hours (long terminal half-life, though the effect remains sleep-centered)
OnsetImmediately before bedtime; faster on an empty stomach (allow a full night of sleep)
EvidenceStrong evidence
Affected systemsnoo.affects.orexinnoo.affects.sleepAnti-fatigue

Contents

DETAILED OVERVIEW

What is Lemborexant?

Lemborexant (Dayvigo) is a prescription sleeping medicine that the US Food and Drug Administration (FDA) approved in 2019 for adults with insomnia, meaning trouble falling asleep or staying asleep. It is approved in the United States, Japan and Canada but not in the EU, and in the US it is a controlled substance.

Unlike older sleeping pills, it does not calm the whole brain; it blocks the receptors of orexin, a messenger substance that maintains wakefulness. In large clinical trials it shortened the time to fall asleep and improved sleep through the night compared with placebo and extended-release zolpidem. It may cause next-day drowsiness, headache and vivid dreams; sleepwalking or driving while not fully awake can also occur, without the person remembering it. Its calming effect adds up with alcohol and other sedatives. It must not be used in narcolepsy and should be avoided in severe liver damage, and its safety in pregnancy has not been shown.

Mechanism

Blocks both receptors of orexin, the wakefulness-promoting messenger

Half-life

~17-19 hours

Legal status

Prescription (FDA 2019, Schedule IV)

Receptor profile

  • Orexin OX2 receptorStrong
  • Orexin OX1 receptorStrong
  • Wakefulness (arousal) driveStrong

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Next-day somnolence or daytime fatigue, especially at the 10 mg dose
  • Headache
  • Vivid or abnormal dreams, nightmares
  • Sleep paralysis, hypnagogic or hypnopompic hallucinations (uncommon)
  • Transient nighttime or morning muscle weakness, cataplexy-like episodes (rare)
  • Complex sleep behaviors (sleepwalking, sleep-driving) without full recall

Contraindications · 6

  • Narcolepsy: orexin blockade is contraindicated
  • Severe hepatic impairment: avoid; limit to 5 mg in moderate impairment
  • Avoid or reduce with strong or moderate CYP3A inhibitors
  • Alcohol and other CNS depressants: additive sedation, avoid combining
  • Pregnancy and breastfeeding: safety not established
  • Severe depression or other conditions causing daytime sleepiness

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Lemborexant is a prescription sleep medication approved by the FDA specifically for treating insomnia. It helps people fall asleep faster and stay asleep longer through the night, and studies suggest it's gentler on natural sleep patterns than older sleeping pills. It's not an over-the-counter supplement, it's a doctor-prescribed drug.

Telegram

Have a question about Lemborexant?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeSleep Support
FormulaC22H20F2N4O2
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.